- Clinical Trials
- April 2025
- 180 Pages
Global
From €2205EUR$2,500USD£1,909GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 100 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2646EUR$3,000USD£2,290GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1323EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1323EUR$1,500USD£1,145GBP
- Drug Pipelines
- April 2025
- 90 Pages
Global
From €1323EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1102EUR$1,250USD£954GBP
- Drug Pipelines
- April 2025
- 40 Pages
Global
From €1102EUR$1,250USD£954GBP
- Drug Pipelines
- April 2025
- 40 Pages
Global
From €1102EUR$1,250USD£954GBP
- Report
- September 2025
- 267 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 182 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 180 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 282 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 243 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 582 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 377 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 288 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 383 Pages
Global
From €5159EUR$5,850USD£4,466GBP

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body.
PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more